nitrofurantoin and Inflammatory Response Syndrome, Systemic

nitrofurantoin has been researched along with Inflammatory Response Syndrome, Systemic in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Brima, W; Lang, V; O'Connor, RA; Patel, V1
Chadha, A; Gandotra, SD; Patel, DB; Smotrys, MA1
Cohee, BM; Forster, CJ; Hartzell, JD; Wood-Morris, RN1
Bag, S; Ganesamoni, R; Kumar, S; Mandal, AK; Singh, SK; Taneja, N1

Other Studies

4 other study(ies) available for nitrofurantoin and Inflammatory Response Syndrome, Systemic

ArticleYear
Systemic Inflammatory Response Syndrome from Nitrofurantoin: A Case Report.
    The American journal of case reports, 2022, Mar-16, Volume: 23

    Topics: Aged; Anti-Bacterial Agents; Female; Fever; Humans; Leukocytosis; Nitrofurantoin; Systemic Inflammatory Response Syndrome

2022
Systemic inflammatory response syndrome (SIRS) and a left bundle branch block (LBBB) due to nitrofurantoin.
    BMJ case reports, 2017, May-22, Volume: 2017

    Topics: Aged; Anti-Infective Agents, Urinary; Bundle-Branch Block; Female; Humans; Nitrofurantoin; Systemic Inflammatory Response Syndrome; Urinary Tract Infections

2017
Nitrofurantoin-induced systemic inflammatory response syndrome.
    The American journal of the medical sciences, 2009, Volume: 338, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Escherichia coli Infections; Gram-Negative Bacterial Infections; Humans; Male; Nitrofurantoin; Stenotrophomonas; Systemic Inflammatory Response Syndrome; Urinary Bladder Neoplasms

2009
Risk factors for urosepsis following percutaneous nephrolithotomy: role of 1 week of nitrofurantoin in reducing the risk of urosepsis.
    Urological research, 2012, Volume: 40, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Endotoxemia; Female; Humans; Logistic Models; Male; Middle Aged; Nephrostomy, Percutaneous; Nitrofurantoin; Prospective Studies; Risk Factors; Systemic Inflammatory Response Syndrome; Urinary Tract Infections

2012